Transcatheter Valve Therapies (TVT): Featuring Clinical Workshops

Educational Grant Support

Transcatheter Valve Therapies (TVT) 2017 is sponsored by the Cardiovascular Research Foundation and supported through educational grants from commercial supporters.

The educational grant support of our industry colleagues, who, like the Cardiovascular Research Foundation, are dedicated to educating medical professionals and the public to enhance patient outcomes, helps to make this program possible.

The Cardiovascular Research Foundation gratefully acknowledges the following supporters:

MAJOR BENEFACTORS:

Edwards Lifesciences
Medtronic

BENEFACTORS:

Abbott
BioTrace Medical, Inc.
Boston Scientific Corporation
Boston Scientific Corporation – Symetis
HLT, Inc.
JenaValve Technology GmbH
St. Jude Medical

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.